$0.81+0.01|(+0.63%)
52W H: 12.2352W L: 0.7432Beta: -1.61

About Tempest Therapeutics Inc

Frequently Asked Questions

What is the 52-week range for TPST?

The 52-week high is $12.23 and the 52-week low is $0.7432.

What is the P/E ratio for TPST?

The P/E ratio data is currently unavailable.

What is the dividend yield for TPST?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -729.89%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -9760.00%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 2.12.

Analyst Recommendation Trends

Wall Street analyst consensus for TPST over the last few months:

2026-09-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0
2026-08-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0
2026-07-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0
2026-06-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0

Latest TPST News

Tempest Therapeutics Files Prospectus Registering Resale Of Up To 9,534,164 Shares Of Common Stock

 Up to 9,534,164 Shares of Common Stock This prospectus relates to the offer and resale from time to time by the selling stockholders named in this prospectus, referred to as the selling stockholders, of up to 9,534,164

Benzinga9/25/2026

HC Wainwright & Co. Maintains Buy on Tempest Therapeutics, Lowers Price Target to $7

HC Wainwright & Co. analyst Joseph Pantginis maintains Tempest Therapeutics (NASDAQ:TPST) with a Buy and lowers the price target from $11 to $7.

Benzinga9/24/2026

Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors

Accomplished finance and enterprise executive with over 20 years of global leadership in multinational and Fortune 500 companiesBRISBANE, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company developing in vivo CAR-T therapies designed to reset dysfunctional immunity in cancer and autoimmune disease, today announced that Nancy Freda-Smith has been appointed to its board of directors and will serve as Chair of the

Yahoo9/23/2026

Let's take a look at the stocks that are in motion in today's session.

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

ChartMill9/21/2026

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Greenland Mines (NASDAQ:GRML) stock rose 232.6% to $9.48 during Monday's regular session. The company's market cap stands at $9.0 million. GRAIL (NASDAQ:GRAL) shares moved upwards by 31.47% to $106.19.

Benzinga9/21/2026

Unusual volume stocks in Friday's session

In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.

ChartMill9/18/2026

Top movers in Thursday's session

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

ChartMill9/17/2026

Which stocks have an unusual volume on Thursday?

Let's have a look at the stocks with an unusual volume in today's session.

ChartMill9/17/2026

Here are the top movers in Thursday's session.

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.

ChartMill9/17/2026

Let's uncover which stocks are experiencing notable gaps during today's session.

In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down.

ChartMill9/17/2026

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Aethlon Medical (NASDAQ:AEMD) shares rose 330.8% to $6.16 during Thursday's regular session. The market value of their outstanding shares is at $1.0 million. bioAffinity Technologies (NASDAQ:BIAF) shares

Benzinga9/17/2026

These stocks are moving in today's pre-market session

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

ChartMill9/17/2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Aethlon Medical (NASDAQ:AEMD) shares increased by 382.5% to $6.9 during Thursday's pre-market session. The company's market cap stands at $1.0 million. Akanda (NASDAQ:AKAN) stock rose 15.07% to $3.13.

Benzinga9/17/2026

Stay updated with the stocks that are on the move in today's after-hours session.

As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

ChartMill9/16/2026

What's going on in today's session

Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

ChartMill9/16/2026

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers Basel Medical Group (NASDAQ:BMGL) stock moved upwards by 14.1% to $4.68 during Wednesday's after-market session. The market value of their outstanding shares is at $8.3 million. Alaunos Therapeutics

Benzinga9/16/2026

These stocks have an unusual volume in today's session

In today's session, these stocks are experiencing unusual volume.

ChartMill9/16/2026

Keep an eye on the top gainers and losers in Wednesday's session.

Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.

ChartMill9/16/2026

Gapping stocks in Wednesday's session

Let's have a look at the gap up and gap down stocks in today's session.

ChartMill9/16/2026

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 354.9% to $7.37 during Wednesday's regular session. The company's market cap stands at $4.9 million. Q/C Technologies (NASDAQ:QCLS) shares increased by

Benzinga9/16/2026

Discover the top movers in Wednesday's pre-market session.

Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.

ChartMill9/16/2026

Tempest Therapeutics (TPST) Stock Surges Wednesday: What's Driving the Action?

Shares of Tempest Therapeutics Inc (NASDAQ: TPST) are trading sharply higher Wednesday morning as investors respond positively to a strategic agreement expanding the company's next-generation cell therapy pipeline.

Benzinga9/16/2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market session. The company's market cap stands at $4.9 million. Tempest Therapeutics (NASDAQ:TPST) stock moved upwards by

Benzinga9/16/2026

Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket

Tempest shares surged 49.6% on a Senlang CD7 CAR-T option deal, while several small-cap stocks posted sharp premarket gains and losses.

Benzinga9/16/2026

Tempest Therapeutics (TPST) Stock Climbs Over 66% After Hours: Here's Why

Tempest Therapeutics shares soared 66.53% after hours Tuesday following an exclusive option agreement expanding its in vivo CAR-T pipeline.

Benzinga9/16/2026

These stocks are moving in today's after hours session

Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.

ChartMill9/15/2026

Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform

-Transaction complements Tempest’s existing CD7-targeted lipid nanoparticle in vivo CAR-T delivery platform, which is planned to enter the clinic later this year -Lead BCMA/GPRC5D dual-targeting in vivo CAR-T candidate is in Phase 1 dose escalation for relapsed/refractory multiple myeloma -Early clinical observations demonstrate in vivo CAR-T generation and expansion at the current highest evaluable dose, with an initial safety profile supporting continued dose escalation -Additional pipeline ca

Yahoo9/15/2026

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's after-market session. The company's market cap stands at $12.9 million. Jupiter Neurosciences (NASDAQ:JUNS) stock

Benzinga9/15/2026

Tempest Therapeutics Announces Up to $7.5 Million Private Placement

$2.5 million upfront with up to approximately $5 million of potential aggregate gross proceeds upon the exercise in full of warrantsBRISBANE, Calif. , Sept. 11, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (the “Company”), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies for cancer and autoimmune disease, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 3,105,591

Yahoo9/11/2026

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 49.2% to $7.91 during Friday's pre-market session. The company's market cap stands at $3.5 million. Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose

Benzinga9/11/2026

Tempest Therapeutics Commences ~$2.5M Offering Of 3.106M Common Shares At $0.805 Per Share

Tempest Therapeutics, Inc. (Nasdaq: TPST) (the "Company"), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies for cancer and autoimmune disease, today announced

Benzinga9/11/2026

Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

BRISBANE, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies for cancer and autoimmune disease, today announced that Matt Angel, Ph.D., Tempest’s President and Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026 at 2:30 p.m. ET. The webcast will be posted to Tempest’s w

Yahoo9/8/2026

Related Stocks (Peers)

Companies operating in similar sectors to TPST:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-22Smith Nancy Freda+25,000--
2026-06-04Yee John D.+25,000--
2026-06-04Richey William Drake+25,000--
2026-03-31Trojanowski Justin+22,000--
2026-03-31Maestas Nicholas+140,000--
2026-03-24Angel Matthew+231,482--
2026-03-24Angel Matthew+231,482--
2026-03-24Angel Matthew+231,482$2.16$500,001
2026-03-24Angel Matthew+231,482$2.16$500,001
2026-02-04Angel Matthew+269,621--
2026-01-27Simantov Ronit+1,230--
2026-01-27RAAB MICHAEL+1,230--
2026-01-27NICHOL GEOFFREY+1,230--
2026-01-27Pellizzari Christine A+1,230--